Trials / Completed
CompletedNCT01797874
Pazopanib Maintenance for SCLC
Phase II Study of Pazopanib Maintenance for SCLC
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of pazopanib maintenance after 1st line CTx for SCLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pazopanib | Experimental |
| DRUG | Placebo | placebo arm |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2017-02-01
- Completion
- 2017-12-01
- First posted
- 2013-02-25
- Last updated
- 2019-12-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01797874. Inclusion in this directory is not an endorsement.